Crossover investors join Orchard's syndicate in $150M series C

Gene therapy company Orchard Therapeutics Ltd. (London, U.K.) raised $150 million on Aug. 13 in a series C round led by Deerfield Management. Also participating were new investors RA

Read the full 290 word article

User Sign In